StockData
Vicapsys Life Sciences, Inc. logo

Vicapsys Life Sciences, Inc. (VICP) income statement

VICPOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2024, quý kết thúc ngày Sep 30, 2024Last filing: 10-Q on Jan 10, 2025
$0.40+0.00 (0.00%)

Close on Oct 19, 2026Market cap $13.73MP/E –Yield –

Vicapsys Life Sciences, Inc. income statement

Ratios

Latest available, balances at Sep 30, 2024

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2023
82.1%

Financial strength

Current ratio
0.03
Debt to equity
–
Debt to assets
–
Cash to current liabilities
3.3%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?